Brazil receives request for emergency use of Janssen vaccine

Brazil’s national sanitary regulator Anvisa reported it received the request for the emergency use of vaccine Janssen on Wednesday (Mar. 24).

In the first 24 hours, Anvisa should ascertain whether all documents required are available. The emergency use request is evaluated by a multidisciplinary team, with specialists in registration, monitoring, and inspection.

“The team has worked in an integrated manner, with optimized efforts and monitored by the commissions making up three of the agency’s boards,” Anvisa declared.

The period from the document verification to the conclusion of the result is estimated to last seven days, and the process may be halted in case a required document cannot be found.

The Brazilian government has expressed interest in purchasing 38 million doses of the vaccine by Janssen, Johnson & Johnson’s pharmaceutical branch. The delivery of these doses is estimated to take place late this year, with no specific date.